Hepatitis C virus infection (HCV) infects approximately 185 million individuals worldwide. It is a leading cause of chronic liver disease and the primary reason for liver transplantation. The main aim of antiviral treatment is to achieve a sustained virologic response, which means eradication of the virus. The combination of pegylated-interferon and ribavirin was the standardof care for over a decade, despite the long treatment duration and severe adverse effects. The introduction of direct-acting antivirals with pan-genomic properties and excellent tolerance increased rates of SVR and shortened the duration of the therapy. Furthermore, it allowed clinicians to customize HCV therapy according to important clinical parameters such as HCV- ge...
Department of Infectious, Tropical Diseases and Medical Parasitology, Nicolae Testemitsanu State Un...
Background: Hepatitis C is a disease with significant global impact. According to the World Health O...
Current therapy for chronic hepatitis C virus (HCV) infection is effective in less than 50% of genot...
Hepatitis C virus infection (HCV) infects approximately 185 million individuals worldwide. It is a l...
Hepatitis C is a devastating illness which has the potential in the majority of cases to lead to sig...
Hepatitis C infection (HCV) is a major cause of chronic hepatitis and cirrhosis worldwide. Interfero...
Hepatitis C virus (HCV) infection is a prominent cause of chronic liver disease and may lead to seri...
Chronic hepatitis C virus (HCV) infection still represents a major public health problem, as it is t...
Chronic HCV infections represent a major worldwide public health problem and are responsible for a l...
Treatments for chronic hepatitis C has evolved significantly in the past 15 years. The standard of c...
Hepatitis C is an infectious disease of the liver caused by the hepatitis C virus (HCV), which affec...
Viral hepatitis, an inflammatory liver disease, is caused by various genotypes of hepatitis C viruse...
It is estimated that currently, in the world, approximately 3% of the population has chronic hepatit...
Hepatitis C virus (HCV) infection is a leading cause of chronic hepatitis, liver cirrhosis, and hepa...
Advances in understanding the hepatitis C virus (HCV) life cycle and the urgent need to find complem...
Department of Infectious, Tropical Diseases and Medical Parasitology, Nicolae Testemitsanu State Un...
Background: Hepatitis C is a disease with significant global impact. According to the World Health O...
Current therapy for chronic hepatitis C virus (HCV) infection is effective in less than 50% of genot...
Hepatitis C virus infection (HCV) infects approximately 185 million individuals worldwide. It is a l...
Hepatitis C is a devastating illness which has the potential in the majority of cases to lead to sig...
Hepatitis C infection (HCV) is a major cause of chronic hepatitis and cirrhosis worldwide. Interfero...
Hepatitis C virus (HCV) infection is a prominent cause of chronic liver disease and may lead to seri...
Chronic hepatitis C virus (HCV) infection still represents a major public health problem, as it is t...
Chronic HCV infections represent a major worldwide public health problem and are responsible for a l...
Treatments for chronic hepatitis C has evolved significantly in the past 15 years. The standard of c...
Hepatitis C is an infectious disease of the liver caused by the hepatitis C virus (HCV), which affec...
Viral hepatitis, an inflammatory liver disease, is caused by various genotypes of hepatitis C viruse...
It is estimated that currently, in the world, approximately 3% of the population has chronic hepatit...
Hepatitis C virus (HCV) infection is a leading cause of chronic hepatitis, liver cirrhosis, and hepa...
Advances in understanding the hepatitis C virus (HCV) life cycle and the urgent need to find complem...
Department of Infectious, Tropical Diseases and Medical Parasitology, Nicolae Testemitsanu State Un...
Background: Hepatitis C is a disease with significant global impact. According to the World Health O...
Current therapy for chronic hepatitis C virus (HCV) infection is effective in less than 50% of genot...